Marc Dunoyer, formerly global head of rare diseases at GlaxoSmithKline Plc, will join AstraZeneca Plc to fill the newly created position of executive vice president, global portfolio & product strategy. In this position he will report to Pascal Soriot, the chief executive, and will be a member of the company’s senior executive team. At GSK, Mr Dunoyer had been chairman of GSK Japan and a member of the corporate executive team. He holds an MBA from the Hautes Etudes Commerciales in Paris and has a Bachelor of Law degree from Paris University. He will join AstraZeneca in the second quarter of 2013.
AstraZeneca announced the appointment on 21 March 2013.
Copyright 2013 Evernow Publishing Ltd.